D
The startup provides a multigene assay kit that analyzes somatic mutation genes specific to breast cancer, enabling precise prognosis predictions for treatment selection. This technology enhances clinical decision-making by equipping physicians with actionable insights derived from genetic data.
Updated 3 months ago
Funding
$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup provides a multigene assay kit that analyzes somatic mutation genes specific to breast cancer, enabling precise prognosis predictions for treatment selection. This technology enhances clinical decision-making by equipping physicians with actionable insights derived from genetic data.